thalidomide |
50-35-1 |
Thalomid |
2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione |
(+/-)-THALIDOMIDE |
Sedoval |
Corronarobetin |
Psycholiquid |
Psychotablets |
Theophilcholine |
Algosediv |
Asmadion |
Bonbrain |
Calmorex |
Contergan |
Distaval |
Ectiluran |
Enterosediv |
Gastrinide |
Glutanon |
Hippuzon |
Neosedyn |
Neosydyn |
Nerosedyn |
Neufatin |
Neurodyn |
Neurosedin |
Neurosedym |
Nevrodyn |
Noctosediv |
Pantosediv |
Polygripan |
Profarmil |
Quetimid |
Quietoplex |
Sandormin |
Sedimide |
Sedisperil |
Shinnibrol |
Softenil |
Softenon |
Talargan |
Talismol |
Telargean |
Tensival |
Thalinette |
Valgraine |
Asmaval |
Calmore |
Glupan |
Grippex |
Imidene |
Isomin |
Kevadon |
Nibrol |
Noxodyn |
Pangul |
Sleepan |
Slipro |
Talimol |
Telagan |
Thalin |
Valgis |
Yodomin |
N-Phthaloylglutamimide |
Sedin |
Predni-Sediv |
Imida-lab |
Poly-Giron |
Sedalis sedi-lab |
Shin-naito S |
Neaufatin |
Asidon 3 |
Pro-ban M |
Imidan (peyta) |
N-Phthalylglutamic acid imide |
Ulcerfen |
3-Phthalimidoglutarimide |
alpha-Phthalimidoglutarimide |
Bonbrrin |
Distaxal |
Distoval |
Talidomida |
Kedavon |
(+-)-Thalidomide |
K-17 |
2,6-Dioxo-3-phthalimidopiperidine |
Thalidomide Celgene |
NSC-66847 |
alpha-N-Phthalylglutaramide |
N-(2,6-Dioxo-3-piperidyl)phthalimide |
Glutarimide, 2-phthalimido- |
N-Phthalyl-glutaminsaeure-imid |
alpha-(N-Phthalimido)glutarimide |
K 17 |
E-217 |
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)- |
1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline |
.alpha.-N-Phthalylglutaramide |
Phthalimide, N-(2,6-dioxo-3-piperidyl)- |
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione |
MFCD00153873 |
CHEMBL468 |
Thalidomide (soluble form) |
2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione |
2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
.alpha.-Phthalimidoglutarimide |
2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione |
Thalomide |
(+-)-N-(2,6-Dioxo-3-piperidyl)phthalimide |
CHEBI:74947 |
.alpha.-(N-Phthalimido)glutarimide |
NSC66847 |
2-(2,6-Dioxo-piperidin-3-yl)-isoindole-1,3-dione |
NSC-527179 |
Pro-Bam M |
N-(2,6-dioxo-3-piperidinyl)phthalimide |
NCGC00015989-09 |
Talidomide DCIT |
Thalidomidum |
Neurosedyn |
Sedalis |
Talidomide |
Telargan |
DSSTox_CID_2524 |
DSSTox_RID_76611 |
DSSTox_GSID_22524 |
Talidomida INN-Spanish |
Thalidomidum INN-Latin |
Thalidomine USP26 |
Synovir |
Talizer |
(?)-Thalidomide |
Thaled |
Phthalimide,6-dioxo-3-piperidyl)- |
ENMD 0995 |
WLN: T56 BVNVJ C- DT6VMVTJ |
Thalomid (TM) |
Thalomid (TN) |
1012310-87-0 |
Thalidomide Pharmion |
Thaled (TN) |
N-Phthalyl-glutaminsaeure-imid German |
N-Phthalimidoglutamic acid imide |
HSDB 3586 |
1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)- |
SR-01000076184 |
EINECS 200-031-1 |
NSC 527179 |
BRN 0030233 |
Celgene |
Pharmion |
Talinol |
Thalidomide (JAN/USP/INN) |
AI3-50606 |
CCRIS 8148 |
(y)-Thalidomide |
Thalidomide,(S) |
CAS-50-35-1 |
Prestwick_463 |
Thalidomide USAN:USP:INN:BAN:JAN |
(A+/-)-Thalidomide |
Prestwick0_000192 |
Prestwick1_000192 |
Prestwick2_000192 |
Prestwick3_000192 |
Spectrum2_000707 |
Spectrum3_001715 |
Spectrum4_001087 |
Spectrum5_001791 |
(.+/-.)-Thalidomide |
UPCMLD-DP139 |
Thalomid (TN) (Celgene) |
SCHEMBL7581 |
NCIOpen2_003188 |
Lopac0_001224 |
BSPBio_000143 |
BSPBio_001156 |
BSPBio_003330 |
KBioGR_000496 |
KBioGR_001474 |
KBioGR_002322 |
KBioSS_000496 |
KBioSS_002324 |
2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione |
MLS000069353 |
ARONIS24496 |
DivK1c_000051 |
SPECTRUM1503607 |
SPBio_000893 |
SPBio_002064 |
BPBio1_000159 |
GTPL7327 |
DTXSID9022524 |
SCHEMBL15197560 |
UPCMLD-DP139:001 |
HMS500C13 |
KBio1_000051 |
KBio2_000496 |
KBio2_002322 |
KBio2_003064 |
KBio2_004890 |
KBio2_005632 |
KBio2_007458 |
KBio3_000911 |
KBio3_000912 |
KBio3_002550 |
KBio3_002802 |
cMAP_000022 |
NINDS_000051 |
Bio1_000387 |
Bio1_000876 |
Bio1_001365 |
Bio2_000418 |
Bio2_000898 |
HMS1362J17 |
HMS1568H05 |
HMS1792J17 |
HMS1922E12 |
HMS1990J17 |
HMS2090O05 |
HMS2093G15 |
HMS2095H05 |
HMS2234C07 |
HMS3259C22 |
HMS3263F10 |
HMS3266F13 |
HMS3373E06 |
HMS3373G15 |
HMS3403J17 |
HMS3414F19 |
HMS3654A20 |
HMS3678F19 |
HMS3712H05 |
HMS3884I05 |
Pharmakon1600-01503607 |
BCP19772 |
NSC91729 |
NSC91730 |
Tox21_110275 |
Tox21_300580 |
Tox21_501224 |
(+/-)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione |
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (+-)- |
AC-917 |
BBL023439 |
BDBM50070114 |
CCG-39878 |
NSC-91729 |
NSC-91730 |
NSC527179 |
NSC758479 |
STL356025 |
( inverted question mark)-Thalidomide |
AKOS009529198 |
Tox21_110275_1 |
CS-1084 |
DB01041 |
LP01224 |
MCULE-6327754946 |
NC00600 |
NSC-758479 |
SDCCGSBI-0051191.P004 |
(+/-)-Thalidomide, >=98%, powder |
IDI1_000051 |
IDI1_002173 |
NCGC00015989-03 |
NCGC00015989-04 |
NCGC00015989-05 |
NCGC00015989-06 |
NCGC00015989-07 |
NCGC00015989-08 |
NCGC00015989-10 |
NCGC00015989-11 |
NCGC00015989-12 |
NCGC00015989-13 |
NCGC00015989-14 |
NCGC00015989-16 |
NCGC00015989-17 |
NCGC00015989-29 |
NCGC00024708-02 |
NCGC00024708-03 |
NCGC00024708-04 |
NCGC00024708-05 |
NCGC00024708-06 |
NCGC00024708-07 |
NCGC00024708-08 |
NCGC00024708-09 |
NCGC00024708-10 |
NCGC00024708-11 |
NCGC00254343-01 |
NCGC00261909-01 |
AS-12367 |
BP-30256 |
BT164465 |
HY-14658 |
NCI60_023904 |
SMR000058524 |
SY052614 |
WLN: T56 BVNVJ C- DT6VMVTJ -D |
WLN: T56 BVNVJ C- DT6VMVTJ -L |
SBI-0051191.P003 |
AB0011813 |
DB-051759 |
Phthalimide,6-dioxo-3-piperidyl)-, (+)- |
Phthalimide,6-dioxo-3-piperidyl)-, (-)- |
AB00052362 |
EU-0101224 |
FT-0600001 |
FT-0602275 |
FT-0631211 |
FT-0675130 |
S1193 |
ST51039042 |
SW196678-4 |
T2524 |
isopropyl (3,4-dichlorophenyl)carbamodithioate |
Phthalimide,6-dioxo-3-piperidyl)-, D-(+)- |
Phthalimide,6-dioxo-3-piperidyl)-, L-(-)- |
(+/-)-N-(2,6-dioxo-3-piperidyl)phthalimide |
C07910 |
D00754 |
J90042 |
AB00052362-11 |
AB00052362-12 |
AB00052362-13 |
AB00052362_14 |
AB00052362_15 |
153T873 |
Q203174 |
SR-01000076184-1 |
SR-01000076184-3 |
SR-01000076184-5 |
SR-01000076184-8 |
Thalidomide N-(2,6-Dioxopiperidin-3-yl)phthalimide |
W-105969 |
BRD-A93255169-001-04-4 |
BRD-A93255169-001-06-9 |
BRD-A93255169-001-24-2 |
Z1550675451 |
1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, (R)- |
1H-Isoindole-1, 2-(2,6-dioxo-3-piperidinyl)-, (S)- |
2-(2,6-dioxoazaperhydroin-3-yl)benzocazoline-1,3-dione |
2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione # |
(??)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione |
(R,S)-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione |
Thalidomide, United States Pharmacopeia (USP) Reference Standard |
( inverted question mark)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione |
2-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione |
|